Phase 1 Systemic Lupus Erythematous Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Childhood-onset Systemic Lupus Erythematous

Cartesian Therapeutics50 enrolled2 locationsNCT07089121

Recruiting

Phase 1

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematous (SLE)

National University of Malaysia5 enrolled1 locationNCT06710717